ADMA Biologics, Inc.
(ADMA - NASDAQ)
10,93 USD
📋 Profilo Aziendale

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

|